The estimated Net Worth of Martin Tyler is at least $559 mil dollars as of 15 March 2013. Martin Tyler owns over 28,606 units of Endologix stock worth over $3,184 and over the last 14 years Martin sold ELGX stock worth over $555,965.
Martin has made over 6 trades of the Endologix stock since 2011, according to the Form 4 filled with the SEC. Most recently Martin sold 28,606 units of ELGX stock worth $441,391 on 15 March 2013.
The largest trade Martin's ever made was selling 28,606 units of Endologix stock on 15 March 2013 worth over $441,391. On average, Martin trades about 7,490 units every 50 days since 2010. As of 15 March 2013 Martin still owns at least 14,472 units of Endologix stock.
You can see the complete history of Martin Tyler stock trades at the bottom of the page.
Martin's mailing address filed with the SEC is 11 STUDEBAKER, , IRVINE, CA, 92618.
Over the last 21 years, insiders at Endologix have traded over $72,068,611 worth of Endologix stock and bought 306,824 units worth $2,023,811 . The most active insiders traders include International, L.P. Elliott, Associates, L.P. Elliott y Capital Management Lp Camber. On average, Endologix executives and independent directors trade stock every 27 days with the average trade being worth of $13,088. The most recent stock trade was executed by Dan Lemaitre on 4 September 2020, trading 51,844 units of ELGX stock currently worth $2,592.
Endologix, Inc. engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA.
Endologix executives and other stock owners filed with the SEC include: